Risk Analysis of AST and ALT level in Patients with Diabetes Mellitus Type 2. Jaringan Laboratorium Medis, [S. l.], v. 4, n. 1, p. 51–55, 2023. DOI: 10.31983/jlm.v4i1.8489. Disponível em: https://analis.poltekkes-smg.net/journal/index.php/jlm/article/view/89. Acesso em: 27 apr. 2025.